Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Yushan Jia,Shuai Quan,Jialiang Ren,Hui Wu,Aishi Liu,Yang Gao,Fene Hao,Zhenxing Yang,Tong Zhang,He Hu

DOI: https://doi.org/10.3389/fonc.2022.1125641

IF: 4.7

2023-01-13

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.974257.].

oncology

What problem does this paper attempt to address?

Corrigendum: Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis.

Jun-Yan Zhu,Han-Lu He,Zi-Mei Lin,Jian-Qiang Zhao,Xiao-Chun Jiang,Zhe-Hao Liang,Xiao-Ping Huang,Hai-Wei Bao,Pin-Tong Huang,Fen Chen

DOI: https://doi.org/10.3389/fonc.2024.1436117

IF: 4.7

2024-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.951973.].
Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

Yin Yang,Jianyang Wang,Wenqing Wang,Tao Zhang,Jingjing Zhao,Yu Wang,Yexiong Li,Luhua Wang,Nan Bi

DOI: https://doi.org/10.3389/fonc.2022.1007862

IF: 4.7

2022-08-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.810580.].

oncology
Corrigendum: Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

Kai Li,Yantao Zhang,Sinan Tian,Qingguo Su,Yanhui Mei,Wei Shi,Jingyuan Cao,Lijuan Song

DOI: https://doi.org/10.3389/fonc.2024.1469673

2024-08-12

Abstract:[This corrects the article DOI: 10.3389/fonc.2024.1360404.].
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from 18F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma

Li Zhang,Yu Liu,Ying Ding,Yinqian Deng,Huanyu Chen,Fan Hu,Jun Fan,Xiaoli Lan,Wei Cao

DOI: https://doi.org/10.3389/fonc.2023.1351842

IF: 4.7

2024-01-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1065744.].

oncology
Corrigendum: Magnetic resonance imaging prognostic factors for survival and relapse in dogs with meningoencephalitis of unknown origin

Rita Gonçalves,Steven De Decker,Gemma Walmsley,Thomas W Maddox

DOI: https://doi.org/10.3389/fvets.2024.1456528

2024-07-23

Abstract:[This corrects the article DOI: 10.3389/fvets.2024.1370882.].
Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]

Jyothirmayi Velaga,Kae Jack Tay,Guanqi Hang,Yu Guang Tan,John S P Yuen,Melvin L K Chua,Rajan T Gupta,Thomas J Polascik,Nye Thane Ngo,Yan Mee Law

DOI: https://doi.org/10.1016/j.ejro.2024.100556

2024-02-23

Abstract:[This corrects the article DOI: 10.1016/j.ejro.2023.100529.].
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: H3K27M mutation doesn't mean worse prognosis in old patients.

Xiao Mu Hu,Xiao Yu Nie,Kai Lun Xu,Yin Wang,Feng Tang,Zun Guo Du,Ji Xiong

DOI: https://doi.org/10.3389/fonc.2022.1061604

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.912166.].
Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Daling Dong,Shixin Zhang,Bin Jiang,Wei Wei,Chao Wang,Qian Yang,Tingzhi Yan,Min Chen,Liken Zheng,Weikang Shao,Gang Xiong

DOI: https://doi.org/10.3389/fonc.2023.1275851

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1222716.].

oncology
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Corrigendum: H3K27M mutation doesn’t mean worse prognosis in old patients

Xiao Mu Hu,Xiao yu Nie,Kai lun Xu,Yin Wang,Feng Tang,Zun guo Du,Ji Xiong

DOI: https://doi.org/10.3389/fonc.2022.1061604

IF: 4.7

2023-01-12

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.912166.].

oncology
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Tingting Deng,Yang Liu,Jialang Zhuang,Yizhe Tang,Qin Huo

DOI: https://doi.org/10.3389/fonc.2022.979968

IF: 4.7

2022-08-22

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.632042.].

oncology
Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

Weifeng Wang,Guankai Huang,Hansen Lin,Lei Ren,Liangmin Fu,Xiaopeng Mao

DOI: https://doi.org/10.3389/fonc.2023.1216134

IF: 4.7

2024-01-09

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1102392.].

oncology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors

Haotian Liu,Kai Huang,Tao Li,Tielong Yang,Zhichao Liao,Chao Zhang,Lijie Xiang,Yong Chen,Jilong Yang

DOI: https://doi.org/10.3389/fonc.2021.688620

IF: 4.7

2021-04-20

Frontiers in Oncology

Abstract:[This corrects the article .].

oncology
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Yaxin Chen,Lei Xia,Yuxuan Peng,Gang Wang,Liyun Bi,Xue Xiao,Cui Li,Weimin Li

DOI: https://doi.org/10.3389/fonc.2023.1309950

IF: 4.7

2023-11-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.947808.].

oncology
Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Linlin Xiao,Yvonne M. Mowery,Brian G. Czito,Yajing Wu,Guangbin Gao,Chang Zhai,Jianing Wang,Jun Wang

DOI: https://doi.org/10.3389/fonc.2022.827810

IF: 4.7

2022-02-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.652509.].

oncology

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Corrigendum: Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis.

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

Corrigendum: Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Predictive value of intratumoral-metabolic heterogeneity derived from 18F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma

Corrigendum: Magnetic resonance imaging prognostic factors for survival and relapse in dogs with meningoencephalitis of unknown origin

Corrigendum to "Surveillance one year post focal cryotherapy for clinically significant prostate cancer using mpMRI and PIRADS v2.1: An initial experience from a prospective phase II mandatory biopsy study" [Eur. J. Radiol. Open 11 (2023) 100529]

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: H3K27M mutation doesn't mean worse prognosis in old patients.

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: H3K27M mutation doesn’t mean worse prognosis in old patients

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors

Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis